Targeting Neutrophils to Treat Acute Respiratory Distress Syndrome in Coronavirus Disease

This review describes targeting neutrophils as a potential therapeutic strategy for acute respiratory distress syndrome (ARDS) associated with coronavirus disease 2019 (COVID-19), a pandemic caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). Neutrophil counts are significantly e...

Descripción completa

Detalles Bibliográficos
Autores principales: Chiang, Chih-Chao, Korinek, Michal, Cheng, Wei-Jen, Hwang, Tsong-Long
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2020
Materias:
Pharmacology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7583590/
https://www.ncbi.nlm.nih.gov/pubmed/33162887
http://dx.doi.org/10.3389/fphar.2020.572009

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7583590/
https://www.ncbi.nlm.nih.gov/pubmed/33162887
http://dx.doi.org/10.3389/fphar.2020.572009

Ejemplares similares